L3Harris Technologies Business Sale Proceeds decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $831.00M to $0.00.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $1.72B | $5.75M | $5.75M | $5.75M | $5.75M | $17.75M | $17.75M | $17.75M | $17.75M | $0.00 | $831.00M | $831.00M | $0.00 |
| QoQ Change | — | >999% | -99.7% | +0.0% | +0.0% | +0.0% | +208.7% | +0.0% | +0.0% | +0.0% | -100.0% | — | +0.0% | -100.0% |
| YoY Change | — | — | — | — | +91.7% | -99.7% | +208.7% | +208.7% | +208.7% | +208.7% | -100.0% | >999% | — | -100.0% |